[1] W. H. Organization, “WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020,” Internet] World Heal. Organ., 2020.
[2] Y. Huang et al., “Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis,” Travel Med. Infect. Dis., 2020.
[3] R. Lu et al., “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding,” Lancet, vol. 395, no. 10224, pp. 565–574, 2020.
[4] C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China,” Lancet, vol. 395, no. 10223, pp. 497–506, 2020.
[5] P. Vetter, D. L. Vu, A. G. L’Huillier, M. Schibler, L. Kaiser, and F. Jacquerioz, “Clinical features of covid-19.” British Medical Journal Publishing Group, 2020.
[6] Y. Xiong et al., “Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes,” Invest. Radiol., 2020.
[7] B. M. Henry, M. H. S. De Oliveira, S. Benoit, M. Plebani, and G. Lippi, “Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis,” Clin. Chem. Lab. Med., vol. 58, no. 7, pp. 1021–1028, 2020.
[8] J. Bao, C. Li, K. Zhang, H. Kang, W. Chen, and B. Gu, “Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19,” Clin. Chim. Acta, 2020.
[9] F. Wang et al., “Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia,” J. Infect. Dis., vol. 221, no. 11, pp. 1762–1769, 2020.
[10] M. Xiong, X. Liang, and Y. Wei, “Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID‐19): a meta‐analysis,” Br. J. Haematol., 2020.
[11] T. Iba, J. H. Levy, M. Levi, and J. Thachil, “Coagulopathy in COVID‐19,” J. Thromb. Haemost., 2020.
[12] I. Huang and R. Pranata, “Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis,” J. Intensive Care, vol. 8, no. 1, pp. 1–10, 2020.
[13] L. Tan et al., “Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study,” Signal Transduct. Target. Ther., vol. 5, no. 1, pp. 1–3, 2020.
[14] C. Lawrence, “Diagnosis from the blood smear.,” N. Engl. J. Med., vol. 353, no. 17, p. 1862, 2005.
[15] B. J. Bain, I. Bates, and M. A. Laffan, Dacie and Lewis Practical Haematology E-Book. Elsevier Health Sciences, 2016.
[16] W. Van Der Meer, W. Van Gelder, R. de Keijzer, and H. Willems, “The divergent morphological classification of variant lymphocytes in blood smears,” J. Clin. Pathol., vol. 60, no. 7, pp. 838–839, 2007.
[17] M. W. Simon, “The atypical lymphocyte,” Int. Pediatr., vol. 18, no. 1, pp. 20–22, 2003.
[18] T. G. Gross, “Infectious mononucleosis and other Epstein-Barr virus related disorders,” Wintrobe’s Clin. Hematol. 11th ed. Philadelphia Lippincott Williams Wilkins, pp. 1849–1850, 2004.
[19] L. Datta and M. P. Menon, “Plasmacytoid lymphocytes: a clue to dengue diagnosis,” Blood, J. Am. Soc. Hematol., vol. 129, no. 15, p. 2202, 2017.
[20] W. J. Chng, H. C. Lai, A. Earnest, and P. Kuperan, “Haematological parameters in severe acute respiratory syndrome,” Clin. Lab. Haematol., vol. 27, no. 1, pp. 15–20, 2005.
[21] V. C. L. Chong, K. G. E. Lim, B. E. Fan, S. S. W. Chan, K. H. Ong, and P. Kuperan, “Reactive lymphocytes in patients with Covid‐19,” Br. J. Haematol., vol. 189, no. 5, p. 844, 2020.
[22] L. Fu et al., “Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis,” J. Infect., 2020.
[23] H. Yun, Z. Sun, J. Wu, A. Tang, M. Hu, and Z. Xiang, “Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients,” Clin. Chim. Acta, 2020.
[24] W. Guan et al., “Clinical characteristics of coronavirus disease 2019 in China,” N. Engl. J. Med., vol. 382, no. 18, pp. 1708–1720, 2020.
[25] D. Gérard, S. Henry, and B. Thomas, “SARS‐CoV‐2: A new aetiology for atypical lymphocytes,” Br. J. Haematol., 2020.
[26] D. Foldes, R. Hinton, S. Arami, and B. J. Bain, “Plasmacytoid lymphocytes in SARS‐CoV‐2 infection (Covid‐19),” Am. J. Hematol., 2020.
[27] J. Osman et al., “Rapid screening of COVID‐19 patients using white blood cell scattergrams, a study on 381 patients,” Br. J. Haematol., 2020.
)
